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management of Cushing's disease while
waiting for pituitary irradiation to become
effective and, in particular, the use ofbromo-
criptine to manage patients with functional
hyperprolactinaemia or prolactin-secreting
microadenomas, is barely mentioned. The
book is primarily for the neurosurgeon, but it
does contain a great deal ofmaterial that will
interest the endocrinologist. The contribu-
tions are well written and the book is well
produced with excellent illustrations. It can
be recommended.
S. M. SHALET
Progress in Radiopharmacology, Vol. 1.
(Ed.) P. H. Cox (1979) Amsterdam:
Elsevier North-Holland. 250 pp. 85 Dfl.
This book contains the papers presented at
the European Symposium on Radiopharma-
cology, held at Noordwijkerhout, The Nether-
lands, inJune 1979.
Twenty papers were presented, 19 from
different centres in Europe and 1 from the
U.S.A. The subjects discussed are: 1-Ionic
tumour-seeking radiopharmaceuticals, 2-
Technetium-labelled skeletal reagents, 3-
TechnetiumIDAderivatives forliver-function
studies.
Each session reviewed the radiochemical
and biological behaviour of the compounds
inrelation tothe physiopathology ofthe organ
or tissue under study, followed by discussion
of the clinical value of these different com-
pounds.
The book is well presented, directly from
typescript, and a good standard is kept
throughout the chapters.
In summary, this is a useful book which
gives a good review of these aspects of radio-
pharmacology, and we look forward to a fur-
ther publication containing new topics of
radiopharmacology.
H. T. TESTA
BCG Vaccine: Tuberculosis-Cancer.
S. R. ROSENTHAL (1980) Littleton, Massa-
chusetts: P.S.G. 410 pp. $25-00.
This is primarily a book on bacteriology,
rather than immunology or oncology, but
nevertheless will also be of value to anyone
interested in the vaccine which has attracted
the attention of immunologists and oncolo-
gists for so long. It describes, with extensive
references, thenature ofthe complex organism
which has been known by the deceptively
simple title of "BCG". Its origin, nearly 60
years ago, its culture and biochemical charac-
teristics and how it is handled, freeze-dried or
preserved as viable vaccine for clinical use,
are described in detail. The strain of BCG,
and how it is cultured and freeze-dried, can
dramatically influence its virulence and
viability, and the immunizing potency of the
final vaccine, and this is stressed throughout.
An account is also given ofthe techniques for
the several routes of administration of BCG
used in both tuberculosis immunization and
tumour immunotherapy, and adverse reac-
tions sometimes associated with them. The
one chapter on BCG in cancer and leukaemia
outlines briefly the clinical experience with
BCG and emphasizes that variable effects of
BCG in different trials may well be associated
with the use of different strains and prepara-
tions. More recently, of course, BCG sub-
cellular components, such as cord factor and
muramyl dipeptide and synthetic analogues,
have superseded BCG to a large extent for
immunological purposes, though these are
outside the scope ofthis book and only briefly
mentioned. In this context, it is a pity that
this volume was not available a few years ago
when BCG itself was attracting such great
attention for immunotherapy trials, but even
now it will be of value to anyone interested
in the biological effects of this fascinating
organism.
M. V. PIMM
Contemporary Hematology/Oncology.
(Eds) J. LoBuE, A. S. GORDON, R. SILBER
& F. M. MUGGIA (1980) New York: Plenum.
330 pp. £29-50.
This book is the successor to "The Year
in Hematology" produced by the same team.
The new title, it seems, was suggested by a
reader who pointed out to the editors that
the original implied that only advances made
during the year under review were included.
In fact, the papers in each of the 3 volumes
so far published explore theoretical concepts
and experimental work which have gradually
evolved over a longer time scale. The editors
then invite distinguished contributors to
review a subject of current practical impor-
tance in the investigation and treatment of
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The present volume maintains the high
standards set by its predecessors. Dr Muggia
has joined the editorial team to provide
additional expertise in the field of oncology,
and to broaden the appeal of the series,
though the spectrum oftopics included is still
likely to be of interest predominantly to the
clinical haematologist rather than the on-
cologist. Amongst chapters which should
interest the latter, however, are those by
Dr Fialkow on the clonal and stem-cell origins
of blood-cell neoplasms, Drs Marks and
McCaffrey on terminal transferase and Drs
Cohen and Cathcart on amyloidosis. The
chapter on the molecular genetics of thalas-
saemia by Drs Orkin and Nathan, and that
on theeffect ofheparin on complement activa-
tion, by Drs Logue and Kelton, will be of
special interest to the haematologist. Drs
Schiffer and Aisner's essay on a rational
approach togranulocyte transfusions istimely
and thoughtful. All these subjects and several
others are discussed by experts in, for the
most part, a commendably lucid style.
Together with the 1977 and 1978 Year
Books, the editors have succeeded in covering
manyofthe "growingpoints" inhaematology,
and the reader who has digested all these
will indeed be well informed, though, to be
sure, at no inconsiderable cost to his pocket!
The editors conclude their preface to the
latest volume wistfully, by pointing out that
some ingenuity is needed to find topics not
already covered in this and comparable series.
Sofartheyhaveachievedtheiraimadmirably.
C. G. GEARY
The Anticancer Drugs. W. B. PRATT &
R. W. RUDDON (1979). Oxford University
Press. 323 pp. £8-50.
This book is a comprehensive account of
currently used cytotoxic agents for cancer
therapy. In general, the text is well pre-
sented and produced in a very readable for-
mat. The initial problem of cancer and the
reasons for drug response are discussed in
some detail, and there follows a description
of individual cytotoxic drugs. Each chapter
is followed by an adequate list of references
for the reader wishing to study a particular
drug in more detail.
I think it would be unlikely to appeal to
current workers in cancer therapy, as it does
not contain sufficient detail. However, its
form is attractive enough to appeal to workers
in other disciplines, and short enough to be
read even by medical students. In support of
this is the attractive price of £8-50 which,
considering the cost of medical texts, is a
considerable achievement for the publishers.
P. WILKINSON